Investing

Karuna Therapeutics Inc : KRTX

KRTX

Stock Data

$329.83

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Karuna Therapeutics Inc is a pioneering biopharmaceutical company based in Boston, Massachusetts, dedicated to developing innovative medicines for psychiatric and neurological conditions. Its flagship product, KarXT, is an oral treatment aimed at managing acute psychosis in schizophrenia patients, along with addressing cognitive symptoms and dementia-related psychosis, including Alzheimer's disease. The company is also exploring other drug candidates targeting muscarinic receptors for various mental health disorders. Karuna Therapeutics boasts strategic partnerships with notable entities like Eli Lilly and Zai Lab, emphasizing its commitment to advancing mental health care.

All KRTX Articles

2 Articles

Paul Ausick | Dec 26, 2023 at 8:55 AM EST

Nano Dimension Buys Stratasys, Bristol Myers’s Shopping Spree, Apple Gets a ‘No’

Another acquisition for Bristol Myers, another acquisition offer from Nano Dimension, and Apple's Watch woes.

Paul Ausick | Dec 22, 2023 at 9:40 AM EST

A Major Acquisition and Other News Ahead of the Holiday Weekend

The last trading day before the Christmas holiday has stocks headed for a mixed opening following a good, not great,…